immuno-surgical management of pancreatic cancer with analysis of cancer exosomes (Cells, 2020, in press).
In the international collaboration with Hirotsu Bio Science Inc., Kinshu-kai Medical Corporation, IDEA Consultants Inc., Kyowa-kai Medical Corporation, Unitech Co. Ltd., as well as department of gastroenterology (Profs Yuichiro Doki and Hidetoshi Eguchi), Takeda et al. updated the state-of-art technology of immuno-surgical strategy of monitoring pancreatic cancer for its early diagnosis and therapy.